Paediatric moyamoya in mainland france: A comprehensive survey of academic neuropaediatric centres

Cerebrovascular Diseases

Volumn 33, Issue 1, 2012, Pages 76-79

  Kossorotoff, M ^a   Herve D ^b   Toulgoat, F ^c   Renaud, C ^d   Presles, E ^d,e   Chabriat, H ^b   Chabrier, S ^e  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

^c BICÊTRE HOSPITAL   (France)

^d University Jean Monnet of Saint Etienne EA3065   (France)

^e INSERM   (France)

Author keywords

Cerebral vasculopathy; Epidemiology; Moyamoya; Paediatric stroke

Indexed keywords

ADOLESCENT; ADULT; CHILD; CHILDHOOD DISEASE; FRANCE; HEALTH SURVEY; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MOYAMOYA DISEASE; OUTCOME ASSESSMENT; PEDIATRIC HOSPITAL; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; SCHOOL CHILD;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; AGE DISTRIBUTION; AGE FACTORS; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHILD, PRESCHOOL; FRANCE; GENETIC PREDISPOSITION TO DISEASE; HEALTH SURVEYS; HUMANS; INCIDENCE; JAPAN; MOYAMOYA DISEASE; PREVALENCE; QUESTIONNAIRES; RESIDENCE CHARACTERISTICS;

EID: 82355172013     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000333424     Document Type: Review

References (13)

1. Braun KP, Bulder MM, Chabrier S, Kirkham FJ, Uiterwaal CS, Tardieu M, Sebire G: The course and outcome of unilateral intracranial arteriopathy in 79 children with ischaemic stroke. Brain 2009; 132: 544-557.
2. Fullerton HJ, Wu YW, Sidney S, Johnston SC: Risk of recurrent childhood arterial ischemic stroke in a population-based cohort: the importance of cerebrovascular imaging. Pediatrics 2007; 119: 495-501. (Pubitemid 46407518)
3. Amlie-Lefond C, Bernard TJ, Sebire G, Friedman NR, Heyer GL, Lerner NB, de Veber G, Fullerton HJ: Predictors of cerebral arteriopathy in children with arterial ischemic stroke: results of the International Pediatric Stroke Study. Circulation 2009; 119: 1417-1423.
4. Sebire G: Transient cerebral arteriopathy in childhood. Lancet 2006; 368: 8-10. (Pubitemid 43947186)
5. Scott RM, Smith ER: Moyamoya disease and moyamoya syndrome. N Engl J Med 2009; 360: 1226-1237.
6. Kuriyama S, Kusaka Y, Fujimura M, Wakai K, Tamakoshi A, Hashimoto S, Tsuji I, Inaba Y, Yoshimoto T: Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke 2008; 39: 42-47.
7. Kuroda S, Houkin K: Moyamoya disease: current concepts and future perspectives. Lancet Neurol 2008; 7: 1056-1066.
8. Uchino K, Johnston SC, Becker KJ, Tirschwell DL: Moyamoya disease in Washington State and California. Neurology 2005; 65: 956-958. (Pubitemid 41362154)
9. Baba T, Houkin K, Kuroda S: Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatr 2008; 79: 900-904.
10. Miao W, Zhao PL, Zhang YS, Liu HY, Chang Y, Ma J, Huang QJ, Lou ZX: Epidemiological and clinical features of moyamoya disease in Nanjing, China. Clin Neurol Neurosurg 2010; 112: 199-203.
11. Yonekawa Y, Ogata N, Kaku Y, Taub E, Imhof HG: Moyamoya disease in Europe, past and present status. Clin Neurol Neurosurg 1997; 99(suppl 2):S58-S60. (Pubitemid 27489065)
12. Kim SK, Cho BK, Phee JH, Lee JY, Chae JH, Kim KJ, Hwang YS, Kim IO, Lee DS, Lee J, Wang KC: Pediatric moyamoya disease: an analysis of 410 consecutive cases. Ann Neurol 2010; 68: 92-101.
13. Lee JY, Phi JH, Wang KC, Cho BK, Shin MS, Kim SK: Neurocognitive profiles of children with moyamoya disease before and after surgical intervention. Cerebrovasc Dis 2011; 31: 230-237.